ALX ONCOLOGY HOLDINGS INC (ALXO) Shareholders’ equity 2018–2022
ALX ONCOLOGY HOLDINGS INC (ALXO) shareholders’ equity at each fiscal year-end, per SEC filings.
$263.5MFY2022 · since FY2018: -$51.8M → $263.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $263.5M | -27.4% |
| FY2021 | $363.0M | -15.5% |
| FY2020 | $429.8M | +708.5% |
| FY2019 | -$70.6M | -36.4% |
| FY2018 | -$51.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice